Health & Biotech
ASX Health: Invex gets ready for Phase 3, Medlab gets US patent. Both jump 13pc this morning
Health & Biotech
BluView: Investors bullish on cannabis sector, and its pot stocks worth watching
Health & Biotech
Apiam confirms APVMA approval for a critical new vaccine in a major breakthrough for Australian cattle health
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
Health & Biotech
Strong FY21 results underpin EZZ’s foothold in growing life sciences sector
Health & Biotech
MGC Pharma opens new production facility in Malta, now set to ramp up sales of CimetrA
Health & Biotech
This health stock has quietly doubled its clinical portfolio since 2018 and doesn’t plan on slowing down
Health & Biotech
InteliCare lands MercyCare contract to provide AI-based smart tech for independent living
Health & Biotech
Osteopore granted patent in China, makes a move into the big Chinese market
Health & Biotech
ASX Health Stocks: Intelicare jumps 35pc on AI in-home sensor tech contract for seniors
Health & Biotech
ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress
Health & Biotech
Osteopore Ltd books improvement in gross margins as it eyes a strong pipeline of post-COVID sales opportunities
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.